When are NSAIDs appropriate in osteoarthritis?

Area of Science:

• Geriatrics
• Rheumatology
• Pharmacology

Background:

• Osteoarthritis (OA) is a common, multifactorial disease in the elderly, with ongoing debate regarding its degenerative versus inflammatory nature.
• While OA is often viewed as degenerative, an inflammatory component is increasingly recognized, especially in cases with crystal deposition.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) pose significant toxicity risks in the geriatric population.

Purpose of the Study:

• To outline a conservative management strategy for osteoarthritis in elderly patients.
• To guide the selection and use of pharmacologic agents, particularly NSAIDs, in geriatric OA management.
• To highlight the importance of non-pharmacologic interventions and risk mitigation.

Main Methods:

• Review of current understanding of osteoarthritis pathophysiology and treatment in the elderly.
• Analysis of NSAID properties, including chemical structure, half-life, and adverse effect profiles.
• Consideration of alternative and adjunctive therapies such as patient education, physiotherapy, intra-articular steroids, topical NSAIDs, and gastroprotection.

Main Results:

• Initial OA therapy in the elderly should emphasize conservative measures: patient education, physiotherapy, and potentially intra-articular steroid injections.
• Simple analgesics are recommended as first-line systemic therapy.
• If NSAIDs are required, propionic acid derivatives with short half-lives, possibly in low doses, are preferred. Topical formulations may reduce systemic adverse effects but are not entirely localized.
• Gastroprotective therapy should be considered for at-risk elderly patients.

Conclusions:

• A cautious, stepwise approach is essential for managing osteoarthritis in older adults.
• Risk-benefit assessment is crucial when selecting pharmacologic treatments, especially NSAIDs.
• Further evaluation of newer agents like cyclooxygenase-2 inhibitors in geriatric OA is warranted.